Equities

Albert David Ltd

ALBERTDAVD:NSI

Albert David Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,493.60
  • Today's Change43.60 / 3.01%
  • Shares traded5.86k
  • 1 Year change+98.09%
  • Beta0.8801
Data delayed at least 15 minutes, as of Sep 20 2024 11:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments2,8521,9171,748
Total Receivables, Net376465360
Total Inventory460521406
Prepaid expenses2.802.334.90
Other current assets, total2512914
Total current assets3,7163,0342,534
Property, plant & equipment, net883803846
Goodwill, net------
Intangibles, net192539
Long term investments328299556
Note receivable - long term3.92----
Other long term assets9.866438
Total assets4,9804,2344,012
LIABILITIES
Accounts payable339321304
Accrued expenses399385440
Notes payable/short-term debt214038
Current portion long-term debt/capital leases6.237.267.87
Other current liabilities, total225236284
Total current liabilities9909891,073
Total long term debt6.026.2311
Total debt335357
Deferred income tax3303.98
Minority interest------
Other liabilities, total121123129
Total liabilities1,1501,1181,218
SHAREHOLDERS EQUITY
Common stock575757
Additional paid-in capital313131
Retained earnings (accumulated deficit)3,6782,9462,629
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total638177
Total equity3,8303,1162,795
Total liabilities & shareholders' equity4,9804,2344,012
Total common shares outstanding5.715.715.71
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.